title: Is the continued use of UK plasma sourced cryoprecipitate justified? Response to Makris.
authors.affiliation: Department of Haematology, Addenbrookes Hospital, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK.
authors.forename: Saad F
authors.initials: SF
authors.lastname: Idris
authors.forename: Andreas V
authors.initials: AV
authors.lastname: Hadjinicolaou
authors.forename: Mark
authors.initials: M
authors.lastname: Sweeney
authors.forename: Craig
authors.initials: C
authors.lastname: Winthrop
authors.forename: Ghaya
authors.initials: G
authors.lastname: Balendran
authors.forename: Martin
authors.initials: M
authors.lastname: Besser
mesh_terms: D000347:Afibrinogenemia / Q000209:etiology* / Q000628:therapy*; D005169:Factor VIII / Q000627:therapeutic use*; D005340:Fibrinogen / Q000627:therapeutic use*; D006801:Humans
chemical_list: D005169:Factor VIII; D005340:Fibrinogen
keywords: coagulation; coagulation factors; haemostasis; transfusion